Lung-MAP Trial Opens Enrollment to Patients With All Types of NSCLC

The Lung-MAP trial, which will allow multiple tumor biomarker-specific treatments to be evaluated in a single umbrella study, is now open to all patients with NSCLC.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2Beh7Yf